Women's health

BIEST 50:50 Cream

Rx · Prescription onlyApplied to the skin

BIEST 50:50 Cream

Menopause, 50:50 cream.

Your plan

$79/mo, $474 billed once for 6 months/mo

$474 billed once for 6 months · unused months refunded on a medical stop

No membership fee · this is the full price · free shipping · monthly supply

Get started
  • Medication, clinician care and dose adjustments, all in one price.
  • ~30-day supply. Your clinician sets your exact dose, so yours may vary; your refill arrives as you finish the last one.

A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.

FDA status: Compounded medication, not FDA-approved.

What it's for

Who it's for

Women who need a stronger estrogen effect through the skin.

How it's different

Half estradiol, half estriol: more estradiol than the 20:80 blend, so it is stronger at the same amount.

How it works

BIEST 50:50 balances estriol and estradiol equally, offering more symptom relief than the 20:80 blend for patients with moderate to severe hot flashes or night sweats. Apply topically for gradual, steady absorption.

How to use it and what arrives

1 tube · lasts 1 month

Your clinician sets your dose: 4 clicks, 0.75 mg · same price at every dose

How
Applied to the skin
Where
inner forearm or inner thigh
How often
Once a day

Good to know

Compounded Bi-Est is not FDA-approved. FDA-approved estradiol patches and gels exist.

What the research shows

Biest is a compounded mix of estriol and estradiol, usually in an 80:20 or 50:50 ratio. It is not FDA-approved, and no outcome trial has tested it; the evidence is pharmacology and a few small studies.

  1. Outcome trials

    No outcome trials

    No randomized trial has tested Biest against heart, bone or cancer outcomes, or against symptom relief. The 2020 National Academies review judged the evidence for compounded bioidentical hormones insufficient, and found most marketing claims unsupported by well-controlled studies.

    National Academies, The Clinical Utility of Compounded Bioidentical Hormone Therapy, 2020
  2. Blood levels

    Less estrogen than a patch

    In a Mayo Clinic randomized trial of 40 postmenopausal women over 16 days, Bi-est cream at the lower doses gave much lower estradiol exposure than a standard estradiol patch with micronized progesterone. The study measured blood levels only, not symptoms or safety.

    Bioidentical compounded hormones: a pharmacokinetic evaluation in a randomized clinical trial, Maturitas 2013
  3. Estriol part

    Limited, mixed evidence

    The same National Academies review found limited, mixed-quality evidence that estriol may help some menopausal symptoms, and insufficient evidence about its long-term safety.

    National Academies, 2020

Compounded Biest is not the product studied in any trial. The idea that the body needs a particular estrogen ratio is not tested in outcome studies. The known risks of estrogen apply to Biest as well.

What this does not say

  • No outcome trial exists for Biest; the blood-level study says nothing about symptoms or safety.
  • Compounded doses are not standardized, so the amount in each capsule or cream can vary.
  • The trials of estrogen cited elsewhere on this page used other products.

Sources

  1. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022
  2. Estrogen and progestogen use in postmenopausal women: 2015 perspective. Lancet, 2015

Safety

FDA status: Compounded medication, not FDA-approved.

Side effects and precautions

  • BIEST is a prescription hormone combination with real benefits and real risks.
  • Common effects include breast tenderness, bloating, nausea, headache, spotting, and injection-site reactions.
  • Estrogen therapy increases risk of blood clots, stroke, gallbladder disease, and, with a uterus, requires progesterone to prevent endometrial cancer.
  • Smoking raises clot risk.

Get care right away

  • Seek care for chest pain, shortness of breath, leg swelling, severe headache, or vision changes.

When it isn't prescribed

  • Not prescribed with breast cancer, blood clots, unexplained vaginal bleeding, liver disease, or pregnancy.

Tell your clinician about every medication.

Questions

Should I start with 20:80 or 50:50?

Your clinician sets the starting ratio based on symptom severity. Starting with 20:80 allows tolerability assessment; if symptoms persist, your clinician may increase to 50:50. Some patients start directly at 50:50 if symptoms are significant.

Is BIEST really bioidentical?

Yes. Estriol and estradiol are both bioidentical, meaning their chemical structure matches what your body made. BIEST is a compounded formula mixing these two in a specific ratio.

Do I need progesterone with BIEST?

If you have a uterus, yes. Estrogen thickens the uterine lining, and progesterone protects it. After hysterectomy, estrogen alone is safe.

Is BIEST better than estradiol alone?

Not necessarily. Both work. BIEST appeals to patients seeking a lower dose, a gentler profile, or a compounded approach.

What if I smoke?

Smoking significantly raises your clot and stroke risk on estrogen. Your clinician may recommend transdermal (topical) over oral forms, or may suggest stopping smoking first.

Still have a question? Message our team

Ready to start with BIEST 50:50 Cream?

$79/mo · $474 billed once for 6 months

Get started
  • Free shipping on every order
  • No membership fee
  • Same price at every dose
  • HSA and FSA accepted

More options in this area